Arrhythmias & electrophysiology
Catheter Ablation Outcomes and Life Expectancy in Very Elderly Atrial Fibrillation Patients: The REHEALTH Atrial Fibrillation (AF) Study
Main finding · Composite of stroke, TIA, systemic embolism, CV events, bleeding or all-cause deathResult — go to the resultAdjusted hazard ratio 0.44Authors' conclusion
Although ablation improved functional and structural outcomes, its prognostic benefit was limited without adjustment but emerged after multivariable correction.
Study context
- Population
- Patients aged ≥80 years with nonvalvular AF, 47 hospitals in Japan, June 2022–December 2023
- Participants
- 703 patients
- Exposure
- Catheter ablation vs nonablation management
- Ablationn = 249
- Nonablationn = 454reference
- Outcome
- Composite of:
- Stroke
- TIA
- Systemic embolism
- CV events
- Bleeding
- All-cause death
- Follow-up
- Median 504 days (Q1-Q3: 375-667 days)
Methodological detailsmulticentre, 47 hospitals in Japan
- Multicentre
- 47 hospitals in Japan
Main finding
As reported in the abstract
Adjusted hazard ratio
0.44
P = 0.029
Observational data: associations, not effects.
Further findings
Symptoms, quality of life, NT-proBNP, left atrial diameter, Mini-Mental State Examination and frailty scores · 1 year
- Ablation improved symptoms, quality of life, NT-proBNP and left atrial diameter, with better preservation of MMSE and frailty scores; significant after adjustment
Original publication
Catheter Ablation Outcomes and Life Expectancy in Very Elderly Atrial Fibrillation Patients: The REHEALTH AF Study. JACC Clin Electrophysiol. Published 24 November 2025. doi:10. 1016/ j. jacep. 2025. 10. 007
Composed by AI from the published abstract and checked against it. How Briefs are made →